Has Traci Salem received payments from drug or device companies?

Yes. Drug and device makers reported $1,961 in general payments to Traci Salem across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Traci Salem did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Traci Salem come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Traci Salem

Adult Health · Clearwater, FLNPI 1841594884

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.8% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,197 and has fallen 98.6% since, to $17 in 2024.

$1,961in general payments, 2019–2025

Across 78 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Daiichi Sankyo Inc.$247
Pfizer$209
AstraZeneca$182
Lilly USA, LLC$146
Gilead$132
Novartis$120
plus $925 from 19 others

What the payments were for

Food & beverage$1,87996%
Education$824%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Daiichi Sankyo Inc.	2	$247
Pfizer	8	$209
AstraZeneca	5	$182
Lilly USA, LLC	2	$146
Gilead	3	$132
Novartis	6	$120
Pharmacyclics LLC, An Abbvie Company	6	$110
Sanofi	5	$95
Amgen	6	$91
AbbVie	5	$87
Merck	5	$85
Johnson & Johnson	3	$80
E.r. Squibb & Sons, L.L.C.	3	$56
Bayer	2	$38
Myovant Sciences Inc.	2	$34
Incyte Corporation	2	$32
Seagen Inc.	2	$31
Array Biopharma Inc	2	$31
Eisai Inc.	2	$28
Blueprint Medicines Corporation	2	$27
Jazz Pharmaceuticals Inc.	1	$24
Deciphera Pharmaceuticals Inc.	1	$22
AMAG Pharmaceuticals, Inc.	1	$21
AVEO Pharmaceuticals, Inc.	1	$18
Genentech USA, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,961 in reported general payments places this provider in the 75th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida →

Other adult health in Clearwater

Jessica MangesClearwater$52K
Marina ValdesClearwater$23K
Patricia PagnottaMaitland$409K
Carly KoelschSarasota$265K
Norma SolisMiami$150K
Ashley PontenbergWinter Park$136K
Jeffrey HernandezMiami$122K
Jamie JohnsonTampa$58K
Sita SwamyOrlando$49K
Cynthia OteroMaitland$31K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →